Asenapine versus olanzapine in the treatment of impulsivity, aggression, and self injuries in patients with borderline personality disorder.

Trial Profile

Asenapine versus olanzapine in the treatment of impulsivity, aggression, and self injuries in patients with borderline personality disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs Asenapine (Primary) ; Olanzapine
  • Indications Borderline personality disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jul 2017 Primary endpoint (Global symptoms assessed with the Clinical Global Impression Scale (CGI-S)) has not been met, according to results published in the CNS Drugs Journal.
    • 24 Jul 2017 Status changed from recruiting to completed, according to results published in the CNS Drugs Journal.
    • 24 Jul 2017 Results published in the CNS Drugs Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top